Ngingakwazi ukusebenzisa i-Actovegin ne-Mildronate ndawonye?

Imithi i-Actovegin ne-Mildronate imiselwe ukuphazamiseka kokusebenza kwesistimu yezinzwa neyenhliziyo, inhliziyo, ubuchopho. Yomibili le mithi izidakamizwa ze-metabolic ezithuthukisa izinqubo ze-metabolic kwezicubu.

Izici Actovegin

Into esebenzayo yesidakamizwa ingukukhishwa okungenamaprotheni egazini lamathole. Isenzo sale ngxenye senzeka ezingeni lamaselula:

• kuthuthukisa izinqubo ze-metabolic;
• kushukumisa ukuthutha ushukela kanye nomoya-mpilo;
• kuvimbela i-hypoxia;
• kuvuselela imetabolism yamandla;
• kuthuthukisa ukuhamba kwegazi;
• kusheshisa ukubuyiselwa kwezicubu ezonakele.

I-Actovegin inomphumela we-neuroprotective. Kubekelwe i-pathologies yesistimu yezinzwa, ukusebenza kwenhliziyo, izitho zombono, emkhakheni we-gynecology kanye ne-dermatology. Isetshenziselwa ikakhulukazi ama-pathologies we-vascular.

Kutholakala ngesimo samathebulethi nesixazululo. Kusetshenziswe i-topical, ukhilimu, i-oyile nejeli iso.

I-Actovegin inomphumela we-neuroprotective.

Wenza kanjani uMildronate

Into esebenzayo (i-meldonium dihydrate) inemvelaphi yokwenziwa. Kuyi-analogue yesakhiwo sento etholakala kumaseli (i-gamma-butyrobetaine). Inomphumela we-antianginal, angioprotective. I-Pharmacodynamics ibonakala ngokulandelayo:

• kuthuthukisa ukulinganisela komoya-mpilo emzimbeni;
• kusheshisa ukuqedwa kwemikhiqizo enobuthi;
• kuthuthukisa ukuhamba kwegazi;
• kwandisa ukongiwa kwamandla.

Umuthi wenyusa amandla, ukusebenza ngokomzimba nangokwengqondo. Kubekelwe izifo zenhliziyo, emkhakheni we-ophthalmology, mayelana nokuphazamiseka kokujikeleza kobuchopho. Isetshenziselwa ikakhulukazi i-cardiopathy.

Kutholakala kumakhompiyutha nama-ampoules ngendlela yesisombululo.

I-Mildronate inomphumela we-antianginal, angioprotective.

Umphumela wokuhlangana

Ukusetshenziswa kanyekanye kwemithi kukhulisa ukusebenza kahle kokwelashwa, kwandisa umphumela wokwelapha futhi kuthuthukisa i-zapnosis.

Zombili lezi zidakamizwa zandisa ukumelana kwezicubu nokushoda komoya-mpilo, kuthuthukise imetabolism. Ukuphatha okuhlanganayo kwenziwa njengokuyalelwa udokotela ophethe ekwelapheni izilonda ezibanzi zesistimu yemithambo yegazi, kungakhathalekile ukuthi kuthini.

Kungani uqoke ngasikhathi sinye

Ukwelashwa okuphelele nezidakamizwa kunqunywe ezimweni:

• ukuphazamiseka kokujikeleza kobuchopho;
• infarction myocardial;
• isifo sohlangothi;
• inhliziyo ischemia;
• ngesikhathi sokutakula ngemuva kokusebenza.

Ukwelashwa okuyinkimbinkimbi nge-Actovegin ne-Mildronate kunqunyelwe i-myocardial infarction.

Ukwelashwa okuyinkimbinkimbi nge-Actovegin ne-Mildronate kumiselwe ukuphazamiseka kokujikeleza kobuchopho.

Ukwelashwa okuyinkimbinkimbi nge-Actovegin ne-Mildronate kunqunyelwe ukuhlaselwa isifo sohlangothi.

Kwezinye izimo, izidakamizwa zingabekwa ngokuhambisana nezidakamizwa ezifana neMexidol neCombilipen.

Contraindication

Ukusetshenziswa kwemithi akufakwa uma kwenzeka umuntu engakwazi ukubekezelela umuthi owodwa. Lapho wabelana, kuyadingeka ukuthi ucabangele ukuphikisana ngemithi yomibili:

• iminyaka engaphansi kweminyaka eyi-18;
• ukukhuphuka kwengcindezi ye-intracranial;
• ukungabekezelelani kwe-fructose;
• ukusweleka kwe-sucrose-isomaltase;
• i-glucose galactose malabsorption;
• ukukhulelwa nokukhipha umunyu.

Ukusetshenziswa kwe-Mildronate ne-Actovegin kuchazwe ngeminyaka engaphansi kweminyaka engu-18.

Ukusetshenziswa kwe-Mildronate ne-Actovegin kuhlanganiswe nengcindezi ye-intracranial ekhulayo.

Ukusetshenziswa kwe-Mildronate ne-Actovegin ku-contraindication ekukhulelweni.

Kuzifo zesibindi nezinso, ukuphathwa kanyekanye kwezidakamizwa kunqunywa ngokuqapha.

Ungayithatha kanjani i-Actovegin ne-Mildronate

Izidakamizwa zingahlanganiswa ngezindlela ezahlukahlukene zomthamo. Uma ukuphathwa okulingene kwezidakamizwa ngendlela yezixazululo kuchaziwe, ngeke kuhlanganiswe kumthamo owodwa. Ezimweni ezinjalo, kunconywa ukubeka isidakamizwa esisodwa ekuseni, nesesibili - ngemuva kwesidlo sakusihlwa.

Ngendlela yamathebulethi namaphilisi, umuthi uhambisana kahle, noma kunjalo, ukuthola kahle, kubalulekile ukugcina isikhathi phakathi kwemithi yemizuzu engama-20 noma engama-30.

Isheduli yokwamukela sinqunyelwa udokotela oholayo.

Imiphumela emibi ye-Actovegin ne-Mildronate

Ukuphatha ngokuhlanganyela kukhulisa amathuba emiphumela emibi. Lokhu kufaka phakathi:

• Izimpawu zokwaliwa (umkhuhlane, ukushaqeka, ukuqubuka kwesikhumba);
• i-tachycardia;
• ukuguqulwa kwezinkomba zokucindezela kwegazi;
• ukuphazamiseka kwe-dyspeptic;
• i-myalgia.

Imiphumela emibi lapho udla izidakamizwa ifaka imishayo yesikhumba.

Imiphumela emibi lapho udla izidakamizwa ifaka ushintsho kumfutho wegazi.

Imiphumela emibi lapho udla izidakamizwa ifaka i-myalgia.

Ukubonakaliswa kwenjabulo noma ubuthakathaka bezinzwa kungenzeka.

Umbono wodokotela

U-Anastasia Viktorovna, udokotela oyinhloko, eMoscow: "Ama-Metabolic agents asiza ukukhulisa ukusebenza kwengqondo. I-actovegin kwesinye isikhathi inqunyelwa kwabesifazane abakhulelwe ukuthi bakhulele ngendlela ejwayelekile. Ukuphatha ngokuhlanganyela noMildronate kuyasebenza ekwelapheni izinhliziyo nezifo zemithambozane ngesithombe esiyinkimbinkimbi sokwelashwa."

U-Andrey Yuryevich, isazi semithambo yenhliziyo, uYaroslavl: "Nginikeza ukuphathwa kanyekanye kwemithi ukwandisa ukukhuthazeka kohlelo lwezinzwa ezifweni eziningi."

Ukubuyekezwa kweziguli mayelana ne-Actovegin ne-Mildronate

UMaria, oneminyaka engu-45 ubudala, eSt.

UKonstantin, oneminyaka engama-38, u-Uglich: "Izidakamizwa zisize ukwenza ngcono lesi simo, zachazwa ngudokotela nge-ischemia yenhliziyo. Imiphumela yabonwa, kepha imnene futhi ayizange iphazamise ukwelashwa."